Cargando…
The Landscape of CAR-T Cell Clinical Trials against Solid Tumors—A Comprehensive Overview
SIMPLE SUMMARY: Certain immune cells, namely T cells, of cancer patients can be genetically manipulated to express so-called chimeric antigen receptors (CARs), which enables these cells to kill the tumor cells after recognition by the receptor. This therapy is very successful in the treatment of hem...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563774/ https://www.ncbi.nlm.nih.gov/pubmed/32916883 http://dx.doi.org/10.3390/cancers12092567 |